BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE
Generic: BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE
HospiraManufacturer
INFILTRATION, PERINEURALRoute
BUPIVACAINE HYDROCHLORIDEActive Substance
1988-06-16Original Approval
BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE is FDA application ANDA071167, sponsored by HOSPIRA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
CHONDROLYSIS
22 reports
2
MUSCULOSKELETAL PAIN
18 reports
3
OSTEOARTHRITIS
9 reports
4
JOINT RANGE OF MOTION DECREASED
8 reports
5
SYNOVITIS
8 reports
6
JOINT INJURY
6 reports
7
ROTATOR CUFF SYNDROME
6 reports
8
MUSCULOSKELETAL DISCOMFORT
5 reports
9
ACTIVITIES OF DAILY LIVING IMPAIRED
4 reports
10
BURSITIS
4 reports